Skip to main content
NCBI home page
PLOS One logoLink to PLOS One
. 2019 Dec 12;14(12):e0218497. doi: 10.1371/journal.pone.0218497

Health conditions associated with overweight in climacteric women

Maria Suzana Marques 1,2,#, Ronilson Ferreira Freitas 1,#, Daniela Araújo Veloso Popoff 1,2,#, Fernanda Piana Santos Lima de Oliveira 2,*,#, Maria Helena Rodrigues Moreira 3,#, Andreia Maria Araújo Drummond 4,‡, Dorothéa Schmidt França 2,‡, Luís Antônio Nogueira dos Santos 1,2,‡, Marcelo Eustáquio de Siqueira e Rocha 1,‡, João Pedro Brant Rocha 4,‡, Maria Clara Brant Rocha 5,‡, Maria Fernanda Santos Figueiredo Brito 1,#, Antônio Prates Caldeira 1,2,#, Fabiana Aparecida Maria Borborema 2,‡, Viviane Maria Santos 2,‡, Josiane Santos Brant Rocha 1,2,#
Editor: Nayanatara Arun Kumar6
PMCID: PMC6907811  PMID: 31830047

Abstract

This study aims to investigate the association between health conditions and overweight in climacteric women assisted by primary care professionals. It is a cross-sectional study conducted with 874 women from 40 to 65 years of age, selected by probabilistic sampling between August 2014 and August 2015. In addition to the outcome variable, overweight and obesity, other variables such as sociodemographic, reproductive, clinical, eating and behavioural factors were evaluated. Descriptive analyses of the variables investigated were performed to determine their frequency distributions. Then, bivariate analyses were performed through Poisson regression. For the multivariate analyses, hierarchical Poisson regression was used to identify factors associated with overweight and obesity in the climacteric period. The prevalence of overweight and obesity was 74%. Attending public school (PR: 1.30–95% CI 1.14–1.50), less schooling (PR: 1.11–95% CI 1.01–1.23), gout (PR: 1.18–95% CI 1.16–1.44), kidney disease (PR: 1.18–95% CI 1.05–1.32), metabolic syndrome (MS) (PR: 1.19–95% CI 1.05–1.34) and fat intake (PR: 1.12–95% CI 1.02–1.23) were considered risk factors for overweight. Having the first birth after 18 years of age (PR: 0.89–95% CI 0.82 to 0.97) was shown to be a protective factor for overweight and obesity. The presence of overweight and obesity is associated with sociodemographic, reproductive, clinical and eating habits.

Introduction

Brazil has been experiencing a rapid process of demographic and epidemiological transition, leading to the frequent occurrence of chronic degenerative diseases[1]. The increase in the prevalence of overweight, represented by overweight and obesity, among the elderly female population raises great concern in developed and developing countries. Since overweight and obesity are risk factors for adverse health events[2], such as disturbances in lipid and glucidic metabolism, psychological stress and sleep alterations, there is an increased risk of cardiovascular diseases[3], musculoskeletal disease, acute myocardial infarction[4], cancer[5] and worse quality of life[6] among patients who are overweight and obese in comparison to those who are satisfied with their body weight[7].

Overweight and obesity have become public health problems worldwide. The projection for 2025 is that approximately 2.3 billion adults will be overweight, and more than 700 million will be obese. According to a study conducted in 2016, the rate of overweight among Brazilian women is 50.5%, and this this frequency increases with age up to 64 years[8].

Epidemiological data associating excess weight with behavioural and clinical variables in climacteric women[9], using probabilistic samples[10], are still scarce. Considering that the climacteric period is an important part of the life cycle of women and that this period is related to the potential peak of fat mass and obesity in this group, the current study aimed to investigate the association between health conditions and an excess weight ratio in climacteric women assisted by primary care professionals, since this phase may assume pathological characteristics or be associated with other chronic diseases.

Materials and methods

This is a component study of the project entitled “Health problems of climacteric women: an epidemiological study”, conducted in the city of Montes Claros, Minas Gerais, Brazil, whose central theme is the health of climacteric women. This project was developed by a group of researchers and considers the central theme in the following lines of research: metabolic syndrome, mental health, obesity, quality of life, sleep disorders, health perception, urinary incontinence, perception of climacteric symptoms and levels of physical activity; each of these themes was developed by researchers who make up the research group.

A cross-sectional and analytical study was carried out in the city of Montes Claros, Minas Gerais, Brazil, from August 2014 to August 2015; the target population consisted of 30,801 climacteric women enrolled in 73 health care units, excluding pregnant, postpartum or bedridden women. This study was carried out in the Family Health Strategy (FHS) system, which represents the primary health care (PHC) mechanism in the public health system in Brazil[11].

Sampling was of the probabilistic type, and the selection of the sample occurred in two stages. Each health care unit team was taken as a conglomerate, from which 20 units were drawn, covering the urban and rural areas for data collection. Following this stage, a proportional number of women were randomly selected according to the climacteric stratification criteria of the Brazilian Society of Climacteric women (SOBRAC), in 2013[12]. For each unit, 48 women were selected; a total of 960 women summoned. To incorporate the structure of the complex sampling plan in the statistical analysis of the data, each interviewee was associated with a weight (w), which corresponded to the inverse of their probability of inclusion in the sample (f)[13]. Women between 40 and 65 years of age who were enrolled in the selected teams and physically able to respond to the questionnaires and be submitted to anthropometric measurements and laboratory tests (12-hour fasting) were considered eligible to participate in the study. The researchers previously trained all data collectors and interviewers and maintained supervision during the data collection stage. After training the interviewers and prior to the actual data collection, a pilot study was conducted in a unit of the FHS, with women belonging to the age group studied and not part of the final sample. The pilot study allowed the questionnaire and the interviewers' performance to be tested in practice. After this phase, the field research was started. Adjustments to the data collection instrument were not required. After selection, the women were invited to arrive for research participation on a previously established date. The final sample consisted of 874 climacteric women who were invited to sign the informed and post-informed consent forms.

Overweight and obesity, which was considered the outcome variable of this work was evaluated by body mass index (BMI). Despite the inclusion of some patients who were over 60 years old, women were categorized into eutrophic (BMI <25 kg/m2) and overweight (IMC ≥ 25 kg/m2), following a categorization model used in other studies with similar population groups[14, 15, 16]. Initially, women were weighed wearing light clothing and without footwear, in an orthostatic position, with their feet together and arms relaxed beside the body, by a mechanical anthropometric medical scale (Balmak 11®) with a capacity of 150 kg and weight increments divided into 100g. The stature was measured by an anthropometer (SECA 206®) that was fixed to a flat wall and was without skirting. In this measurement, the women were instructed to keep their feet together and stand in an upright position, with their head positioned in the Frankfurt plane. For the calculation of BMI, the body weight in kilograms was divided by the squared height, expressed in metres (BMI = P/A2).

The women answered questions related to the independent variables, which were allocated in three blocks: (1) sociodemographic, (2) reproductive, and (3) clinical, eating and behavioural factors.

The block of sociodemographic variables included age (40–45, 46–51, 52–65 years); type of school (public, private); level of schooling (elementary school I, elementary school II, high school or higher education); marital status (married, separated, divorced, widowed); labour occupation (yes, no); monthly income (≥ 01 minimum wage, <01 minimum wage), where the minimum wage was equivalent to US $217,42 at the time of data collection; number of people residing in the same house (up to 2, more than 2); and skin colour (white, not white).

The reproductive variables comprised the age of menarche (≤ 11 years, 12–14 years and ≥ 15 years), first birth weight (<4000 g; ≥ 4000 g), climacteric symptoms assessed by the Kupperman index[17] (absent/mild; moderate/severe) and age at first delivery (≤ 18 years old, > 18 years).

The clinical, eating and behavioural variables included liver disease (absent, present), gout (absent, present), renal disease (absent, present), metabolic syndrome (MS) (absent, present); urinary incontinence (absent, present), cardiovascular disease risk (low risk, intermediate risk, high risk), drinking (yes, no), fat intake (yes, no), smoking (yes, no), symptoms of depression, quality of sleep and physical activity.

Metabolic syndrome (MS) was evaluated using the Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (NCEP-ATPIII) criteria of the Brazilian Society of Diagnosis and Treatment of MS[18]; urinary incontinence was assessed by the International Consultation on Incontinence Questionnaire-Short Form ICIQ-SF[19]; the risk for cardiovascular diseases was assessed by the Framingham Global Risk Score[20]; the symptoms of depression were evaluated by the Beck Depression Inventory[21]; sleep quality was assessed by the Pittsburgh Sleep Quality Index[22]; and physical activity practice was assessed through the International Physical Activity Questionnaire (IPAQ short version)[23].

The women were submitted to peripheral venous blood collection to analyse the laboratory parameters. Serum triglyceride levels were determined by the colourimetric enzymatic method. The level of high-density lipoprotein (HDL) cholesterol was obtained by selective precipitation of ((low-density lipoprotein (LDL) cholesterol and very low-density lipoprotein (VLDL) cholesterol with dextran sulfate in the presence of magnesium ions, followed by dosing by the enzymatic system cholesterol oxidase/peroxidase with calorimetry and reading, as performed in the total cholesterol dosage, using Labtest® reagents, in a Cobas Mira®[24] apparatus. The lipid profile was analysed according to parameters proposed by the Brazilian Society of Cardiology[25] and fasting glycaemia according to the standards of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus[26].

The data were tabulated in the statistical software Statistical Package for Social Science (SPSS, version 21, Chicago, Illinois). Initially, descriptive analyses of all variables were carried out to determine their frequency distributions, and then, bivariate analyses of the outcome variable with each independent variable were performed using the chi-square test. Gross prevalence ratios (PRs) were estimated with their respective 95% confidence intervals. Variables with a descriptive level (p-value) of less than 0.25 were selected for multivariate analysis using the hierarchical Poisson regression model, adapted to the model proposed by other authors[10]. The model was composed of blocks of distal (sociodemographic variables), intermediate (reproductive) and proximal (clinical, eating and behavioural) variables. Adjusted prevalence ratios (PRs) with their respective 95% confidence intervals were estimated, and only those that presented a descriptive level of p<0.05 remained in the model. At each hierarchical level, the stepwise forward procedure was adopted: the statistically significant variables selected in the bivariate analysis started in the model, and then other variables were added (Fig 1).

Fig 1. Model with the statistically significant variable selected in the bivariate analysis, and then adding other variables.

Fig 1

Open in a new tab

As this study involved humans, it was submitted, evaluated and approved for execution by the Research Ethics Committee of the Faculdades Integradas Pitágoras (Protocol: 817.666).

Results

The sample consisted of 874 women between 40 and 65 years of age, of whom 74.1% were overweight and obese. When categorized by climacteric status, it was observed that postmenopausal women had a higher prevalence of overweight/obesity (54.3%).

The results of the bivariate analysis revealed that the following variables were associated with the overweight and obesity outcome: age between 52 and 65 years (p = 0.184), private school attendance (p = 0.000), less schooling (p = 0.093) (p = 0.0006), liver disease (p = 0.000), gout (p = 0.000), kidney disease (p = 0.106), weight of the 1st child at birth equal to or greater than 4000 g (p = .039), high risk for cardiovascular diseases (p = 0.000), alcohol consumption (p = 0.039) and fat intake (p = 0.065). However, women between 46 and 51 years of age (p = 0.184), who had a late menarche age (p = 0.039) and had children over 18 years old (p = 0.004) experienced a protective effect against overweight and obesity. It should be emphasized that there was a high prevalence of overweight and obesity in all the independent variables presented (Table 1).

Table 1. Sample characteristics and gross prevalence ratios (PRs) for overweight and obesity women according to the sociodemographic, reproductive, clinical, behavioural and eating factors of menopausal women.

Variables n %* Overweight/obesity
(%)* 		Gross PR (CI95%)
 p-value
Sociodemographic
Age 40 to 45 236 27.9 73.2 1.00
0.184
46 to 51 241 26.8 70.0 0.95 (0.85–1.07)
52 to 65 397 45.4 77.0 1.04 (0.95–1.15)
Type of school attended Public 822 97.3 73.2 1.00 0.000
Private 24 2.7 93.6 1.26 (1.11–1.43)
Schooling High school/Graduate 281 31.8 70.9 1.00 0.093
Fundamental II 231 26.6 73.0 1.03 (0.92–1.15)
Fundamental I 358 41.6 77.5 1.11 (1.01–1.21)
Labour occupation Yes 347 40.4 71.7 1.00 0.106
No 520 59.6 76.0 1.07 (0.99–1.16)
Reproductive
Age at menarche 12 to 14 (Normal) 513 60.6 75.9 1.00
0.039
≤ 11 (Early) 101 11.8 79.8 1.06 (0.95–1.18)
≥ 15 (Late) 260 27.6 67.6 0.90 (0.82–1.00)
Weight of 1st child at birth < 4000 g 600 84.8 73.0 1,00 0.050
≥ 4000 g 106 15.2 80.8 1.11 (1.00–1.24)
Climacteric symptoms Absent/Light 541 62.3 72.6 1,00 0.203
Moderate/Intense 332 37.7 76.4 1.05 (0.97–1.14)
Age at first delivery ≤18 years 218 27.3 81.2 1,00 0.004
> 18 years 605 72.7 72.1 0.89 (0.82–0.96)
Clinical, eating and behavioural factors
Liver disease Absent 792 91,6 73.0 1.00
0.000
Present 74 8.4 86.3 1.21 (1.10–1.33)
Gout
 Absent 822 95.4 73.0 1.00 0.000
Present 38 4.6 91.9 1.27 (1.15–1.40)
Kidney disease Absent 700 85.4 72.1 1.00 0.000
Present 119 14.6 88.2 1.20 (1.10–1.31)
Metabolic syndrome Present 317 35.2 59.6 1.00 0.000
Absent 557 64.8 81.9 1.39 (1.25–1.53)
Urinary incontinence Absent 676 77.5 71.9 1.00 0.026
Present 195 22.5 81.2 1.10 (1.01–1.20)
Cardiovascular disease Low risk 388 43.7 66.6 1,00
0.000
Intermediate risk 423 48.4 78.7 1.15 (1.06–1.26)
High risk 66 7.9 87.0 1.31 (1.16–1.46)
Alcoholism No 646 78.8 73.0 1,00 0.239
Yes 163 21.2 79.8 1.06 (0.96–1.16)
Fat intake No 655 80.2 73.0 1.00 0.065
Yes 163 19.8 79.8 1.09 (1.00–1.19)
Open in a new tab

* values corrected by the drawing effect (deff); PR: Gross prevalence ratio; 95% CI: Confidence interval.

Some sociodemographic (marital status, monthly income, number of individuals residing in the same house and colour of skin), clinical and behavioural (smoking, physical activity, depression symptoms, sleep quality) factors did not present significant associations (p <0.250) with overweight and obesity and were not included in the hierarchical model.

The health conditions that were associated with overweight and obesity in the hierarchical model at the distal level were private school attendance (PR = 1.30, p = 0.000) and low level of education (PR = 1.11, p = 0.033). After adjusting for sociodemographic factors, an association at an intermediate level between age at first childbirth above 18 years (PR = 0.90, p = 0.010) was observed, and this variable had a protective effect against the occurrence of overweight and obesity (Table 2). At the proximal level, after adjusting for the potential confounding factors analysed, the presence of gout (RP = 1.18, p = 0.004), MS (PR = 1.29, p = 0.000), kidney disease (PR = 1.19, p = 0.006) and fat intake (PR = 1.12, p = 0.014) were found to be positively associated with overweight and obesity (Table 2).

Table 2. Adjusted prevalence ratios for overweight and obesity according to sociodemographic, reproductive, clinical, eating and behavioural factors of climacteric women.

Variables PR (CI95%)
adjusted		 p value
Sociodemographic (distal level)
Type of school attended Public 1.00
Private 1.30 (1.14–1.50) 0.000
Schooling High School/Graduate 1.00
Fundamental II 1.05 (0.94–1.17) 0.420
Fundamental I 1.11 (1.01–1.23) 0.033
Reproductive (Intermediate level)
Age at first delivery ≤18 years 1.00
> 18 years 0.90 (0.82–0.97) 0.010
Clinical, eating and behavioural factors (proximal level)
Gout Absent 1.00
Present 1.18 (1.05–1.32) 0.004
Metabolic syndrome Absent 1.00
Present 1.29 (1.16–1.44) 0.000
Kidney disease Absent 1.00
Present 1.18 (1.08–1.29) 0.000
Cardiovascular disease Low risk 1.00
Intermediate risk 1.05 (0.95–1.15) 0.332
High risk 1.19 (1.05–1.34) 0.006
Fat intake No 1.00
Yes 1.12 (1.02–1.23) 0.014
Open in a new tab

PR: adjusted prevalence ratio; 95% CI: confidence interval

Discussion

The prevalence of overweight and obesity in the population of the present study was higher than 2/3 of the sample, with a mean BMI of 28.67 ± 6.35 kg/m2 and with a predominance of overweight in postmenopausal women. These findings are in accordance with a study conducted in São Paulo/Brazil, where the mean BMI in postmenopausal women was 29.0 ± 5.6 kg/m2[27].

Weight gain in climacteric women is due to the ageing process and oestrogenic depletion, with a centralized distribution of fat mass related to ovarian failure[28], which leads to a change in the hormonal environment previously dominated by oestrogen to an environment where there is a predominance of testosterone, favouring androgenicity[29]. Additionally, inadequate lifestyle habits, such as a sedentary lifestyle and the consumption of fats and sugars, can lead to physiological and metabolic alterations[30]. The limited perception of body weight and the importance of its control[31] and the use of medications such as antidepressants, analgesics, and anxiolytics[32] also compete for a role in this condition.

Obesity is associated with insulin resistance and chronic inflammation predisposing obese individuals to various diseases, including breast cancer, whose pathogenesis has been linked to increased oestrogen levels[33].

In addition, excessive body weight also contributes to the occurrence of systemic arterial hypertension (SAH), depression and worsening of climacteric symptoms[34]. Together with other comorbidities, excessive body weight impairs the quality of life of women and impacts their functionality[6,35,36].

According to the findings of this study, having attended private school seems to be associated with overweight in the climacteric women. This may be due to an increased accessibility of high caloric foods in childhood and adolescence or maternal obesity during pregnancy36 that leads to weight excess, which could be perpetuated in adult life. However, the literature cannot explain these findings consistently, presenting evidence of a higher prevalence of weight excess among students of private schools in other age groups[37,38].

Nevertheless, some studies have shown an association between less schooling and high BMI[39], in agreement with the present findings, suggesting that a higher level of education may favour healthier living habits, such as the intake of vegetables and fruits[40] and the regular practice of physical activity[41]. Physical activity, including strength and endurance training, has a significant effect on aspects related to women's health in menopause, including favourable aspects of mineral metabolism, such as iron[42], which may also be influenced by probiotic supplementation, which improves the quality of the impaired intestinal microbiota in obese patients[43].

Regarding the gynaecological aspects, having a first delivery that occurred after the age of 18 was shown to be a protective factor for overweight and obesity. Other studies have also shown an association between overweight and obesity, early parturition and parity[44,45]. Findings suggest that younger maternal age at first delivery is independently associated with a higher risk of central obesity and MS in climacteric women[46]. One explanation would be the possibility of a higher number of pregnancies among women with early parturition and lifestyle changes, although the pathophysiology of this association is still unclear and deserves additional study[47]. Multiparity is associated with an increase in the prevalence of MS since it favours abdominal obesity[48] and insulin resistance in climacteric women[49].

The diagnosis of gout is also associated with overweight and obesity in climacteric women. This finding becomes relevant since hyperuricaemia is correlated with insulin resistance, hypertension, obstructive sleep apnoea, chronic renal disease (CKD), MS and elevated cardiovascular risk[50,51]. According to this context, hyperuricaemia may be related to an increase in the prevalence of coronary artery disease (CAD) and to the incidence of major cardiovascular events in climacteric women as an independent risk factor[52]. Chromosomal abnormalities are associated with elevated serum levels of uric acid and gout in postmenopausal women, demonstrating a possible role of sex hormones in the regulation of the urate transporter in gout[53].

An association between kidney disease and overweight and obesity was found in the present study. These data are consistent with the Brazilian Society of Nephrology's Dialysis Survey in 2014, which showed that 37% of dialysis patients were overweight or obese and that overweight and obesity was as a risk factor for CKD[54]. In addition, obesity was associated with MS, which is also a risk factor for the development of CKD[55].

Overweight is related to compensatory hyperfiltration, which occurs to meet the metabolic demands increased by body weight, with possible damage to the kidneys and increased risk of long-term glomerulopathy, in addition to being a risk factor for nephrolithiasis and kidney cancer. The obese patient also has a higher relative risk for developing albuminuria and a decrease in the glomerular filtration rate, even without CKD[56].

In climacteric women, with increased risk for obesity, MS becomes more prevalent, increasing the incidence of cardiovascular disease and the risk of acute myocardial infarction (AMI)[57], a vulnerability attributed to the decrease of oestrogen and insulin resistance[58]. The association between overweight and obesity and MS was observed in the present study with a consequent risk elevation for cardiovascular diseases. Another study corroborated these findings and demonstrated that the prevalence of MS was also higher in postmenopausal women[59]. Obesity presents as a possible primary factor for the occurrence of MS and the risk of cardiovascular diseases, since an overweight patient may also have visceral adiposity, which is one of the diagnostic criteria of MS.

Among the overweight and obese women in this study, a diet characterized by fat intake was associated with overweight. A document published by the Health Surveillance Agency points out that excessive consumption of saturated fat, as well as sugars, is related to the development of chronic noncommunicable diseases, including obesity[60]. A balance in fat consumption is a viable strategy for a possible reduction of cardiovascular risk in this population[61], since inadequate diet is the leading cause of cardiovascular mortality[25].

The present study presents as limiting factors the use of BMI as the sole diagnostic criterion for overweight and obesity, as opposed to using other gold standard techniques of body analysis, such as Dual X-ray Densitometry (DEXA). The liver diseases, kidney disease and gout variables were measured by self-report, and it was not possible to establish with precision the different aetiologies of these diseases; however, being able to establish their association in a generic way provoked the need for further studies using more accurate diagnostic tools, such as imaging or laboratory tests. Moreover, this was a cross-sectional study and, therefore, it was unable to establish causality among the studied variables. Despite the presented limitations, the study was carried out with methodological rigor, and the obtained results provide relevant information on the subject in addition to listing variables to be studied in future studies. It should be emphasized that the sample used in the study was representative of the population and was obtained in a probabilistic way, strengthening the results and associations obtained.

In addition, from a socioeconomic point of view, the population studied resides in a region that represents the Brazilian reality with confidence; it is located in a transition zone between what is considered rich Brazil (represented by the southern and southeastern states) and regions of Brazil with characteristics of poverty (represented by the northern and northeastern states). Therefore, the present study reports associations relevant to the health of climacteric women in an emblematic and representative segment of the Brazilian population. These results can be used to implement public policies to assist climacteric women in preventing the occurrence of overweight and its consequences.

Conclusion

The presence of overweight and obesity was associated with climacteric women who had attended private schools, who had low schooling, gout, metabolic syndrome, and kidney disease, who had high cardiovascular risk and who ingested fats in their diet. In turn, having a first delivery after 18 years of age was presented as a protective factor for women not becoming overweight and obese. Monitoring of these modifiable factors is suggested since they were associated with overweight in climacteric women assisted by primary health care services.

Supporting information

S1 File. DATABASE.

(SAV)

Click here for additional data file. (454.4KB, sav)

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.Cunha ACNP, Cunha NNP, Barbosa MT. Geriatric teaching in Brazilian medical schools in 2013 and considerations regarding adjustment to demographic and epidemiological transition. Rev Ass Med Bras. 2016; 62(2): 179–183. 10.1590/1806-9282.62.02.179 [DOI] [PubMed] [Google Scholar]
  • 2.NCD Risk Factors Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. The Lancet. 2016; 387(10026):1377–96. 10.1016/S0140-6736(16)30054-X [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Nogueira IAL, da Cruz EJSN, Fontenele AMM, Figueiredo Neto JA. Alterations in postmenopausal plasmatic lipidome. PLoS ONE. 2018; 13 (9): e0203027 10.1371/journal.pone.0203027 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Silveira EA, Vieira LL, Jardim TV, Souza JD. Obesity and its Association with Food Consumption, Diabetes Mellitus, and Acute Myocardial Infarction in the Elderly Arq. Bras. Cardiol. 2016; 107(6): 509–517. 10.5935/abc.20160182 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Moley KH, Colditz GA. Effects of obesity on hormonally driven cancer in women. Sci Transl Med. 2016; 8(323): 323ps3 10.1126/scitranslmed.aad8842 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Souza Guerra GE, Junior, Prates Caldeira A, Piana Santos Lima de Oliveira F, Santos Figueiredo Brito MF, de Oliveira Silva Gerra KD, Mendes D’Angelis CE, et al. Quality of life in climacteric women assisted by primary health care. PLoS ONE. 2019;14(2):1–13. 10.1371/journal.pone.0211617 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Medeiros de Morais MS, Andrade do Nascimento R, Vieira MCA, Moreira MA, Camara SMAD, Campos Cavalcanti Maciel A et al. Does body image perception relate to quality of life in middle-aged women? PLoS ONE. 2017; 12(9): e0184031 10.1371/journal.pone.0184031 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância de Doenças e Agravos não Transmissíveis e Promoção da Saúde. Vigitel Brasil 2016: vigilância de fatores de risco e proteção para doenças crônicas por inquérito telefônico: estimativas sobre frequência e distribuição sociodemográfica de fatores de risco e proteção para doenças crônicas nas capitais dos 26 estados brasileiros e no Distrito Federal em 2016 / Ministério da Saúde, Secretaria de Vigilância em Saúde, Departamento de Vigilância de Doenças e Agravos não Transmissíveis e Promoção da Saúde.–Brasília: Ministério da Saúde, 2017. 160p.: il. ISBN 978-85-334-2479-1. Available at: http://portalarquivos2.saude.gov.br/images/pdf/2018/marco/02/vigitel-brasil-2016.pdf.
  • 9.Lui Filho JF, Baccaro LF, Fernandes T, Conde DM, Costa-Paiva L, Pinto Neto AM. Factors associated with menopausal symptoms in women from a metropolitan region in Southeastern Brazil: a population-based household survey. Rev Bras Ginecol Obstet. 2015; 37(4):152–8. 10.1590/SO100-720320150005282 [DOI] [PubMed] [Google Scholar]
  • 10.Gonçalves JTT, Silveira MF, Campos MCC, Costa LHR. Overweight and obesity and factors associated with menopause. Ciência & Saúde Coletiva. 2015; 21(4): 1145–56. 10.1590/1413-81232015214.16552015 [DOI] [PubMed] [Google Scholar]
  • 11.Andrade MV, Coelho AQ, Xavier Neto M, Carvalho LR, Atun R, Castro MC. Transition to universal primary health care coverage in Brazil: Analysis of uptake and expansion patterns of Brazil's Family Health Strategy (1998–2012). PLoS ONE. 2018; 13(8): e0201723 10.1371/journal.pone.0201723 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.The North American Menopause Society (NAMS). Menopause Guidebook. Available at: www.menopause.org. Traduzido pela SOBRAC–Associação Brasileira de Climatério. Guia da Menopausa. Ajudando a mulher climatérica a tomar decisões informadas sobre a sua saúde. 7 ed. São Paulo: 2013. ISBN 978-0-9701251-4-9. Available at: http://sobrac.org.br/media/files/publicacoes/00001261_a12361_leigos_rev2mcowfinal.pdf
  • 13.Szwarcwald CL, Damacena GN. Complex Sampling Design in Population Surveys: Planning and effects on statistical data analysis. Rev. bras. epidemiol. [Internet]. 2008; 11(Suppl 1):38–45. 10.1590/S1415-790X2008000500004 [DOI] [Google Scholar]
  • 14.Mason C, Xiao L, Imayama I, Duggan C, Wang CY, Korde L, et al. Vitamin D3 supplementation during weight loss: a double-blind randomized controlled trial. Am J Clin Nutr. 2014. 10.3945/ajcn.113.073734 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Yan LL, Daviglus ML, Liu K, Pirzada A, Garside DB, Schiffer L, Dyer AR, Greenland P. BMI and health-related quality of life in adults 65 years and older. Obes Res. 2004; 12(1): 69–76. 10.1038/oby.2004.10 [DOI] [PubMed] [Google Scholar]
  • 16.Fanelli F, Mezzullo M, Belluomo I, Di Lallo VD, Baccini M, Ibarra Gasparini D et al. Plasma 2-arachidonoylglycerol is a biomarker of age and menopause related insulin resistance and dyslipidemia in lean but not in obese men and women. Mol Metab. 2017; 6(5): 406–415. 10.1016/j.molmet.2017.03.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Kupperman HS, Blatt MHG. Menopausal indice. J Clin Endocrinol. 1953; 13(1): 688–694. [DOI] [PubMed] [Google Scholar]
  • 18.Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Jama 2001. May 16; 285(19): 2486–97. 10.1001/jama.285.19.2486 [DOI] [PubMed] [Google Scholar]
  • 19.Tamanini JTN, Dambros M, D'Ancona CAL, Palma PCR, Netto NR Jr. Validation of the “International Consultation on Incontinence Questionnaire—Short Form” (ICIQ-SF) for Portuguese. Rev Saúde Pública. 2004;38(3)438–44. 10.1590/s0034-89102004000300015 [DOI] [PubMed] [Google Scholar]
  • 20.D'Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743–53. 10.1161/CIRCULATIONAHA.107.699579 [DOI] [PubMed] [Google Scholar]
  • 21.Gorenstein C, Andrade L. Inventário de depressão de Beck: propriedades psicométricas da versão em português. Rev Psiq Clin.1998; 25:245–250. [Google Scholar]
  • 22.Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213. 10.1016/0165-1781(89)90047-4 [DOI] [PubMed] [Google Scholar]
  • 23.Benedetti TRB, Mazo GZ, Barros MV. Aplicação do Questionário Internacional de Atividade Física para avaliação do nível de atividades físicas de mulheres idosas: validade concorrente e reprodutibilidade teste/reteste. Rev Bras Ciên e Mov. 2004; 12(1):25–33. [Google Scholar]
  • 24.Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502. [PubMed] [Google Scholar]
  • 25.Faludi AA, Izar MCO, Saraiva JFK, Chacra APM, Bianco HT, Afiune Neto A et al. Atualização da Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose– 2017. Arq Bras Cardiol 2017; 109(2Supl.1):1–76. 10.5935/abc.20170121 Available at: http://publicacoes.cardiol.br/2014/diretrizes/2017/02_DIRETRIZ_DE_DISLIPIDEMIAS.pdf [DOI] [PubMed] [Google Scholar]
  • 26.Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26(1):S5–20. 10.2337/diacare.26.2007.S5 [DOI] [PubMed] [Google Scholar]
  • 27.Steiner ML, Azevedo LH, Bonacordi CL, Barros AZ, Strufaldi R, Fernandes CE. Avaliação de consumo alimentar, medidas antropométricas e tempo de menopausa de mulheres na pós-menopausa. Rev Bras Ginecol Obstet, 2015; 37(1):16–23. 10.1590/SO100-720320140005138 [DOI] [PubMed] [Google Scholar]
  • 28.Karvonen-Gutierrez C, Kim C. Association of Mid-Life Changes in Body Size, Body Composition and Obesity Status with the Menopausal Transition. Healthcare (Basel), 2016; 13;4(3). 10.3390/healthcare4030042 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Janssen I, Powell LH, Jasielec MS, Kazlauskaite R. Covariation of change in bioavailable testosterone and adiposity in midlife women. Obesity (Silver Spring), 2015; 23(2): 488–494. 10.1002/oby.20974 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Barbalho SM, Bechara MD, Quesada K, Gabaldo MR, Goulart RA, Tofano RJ et al. Metabolic syndrome, atherosclerosis and inflammation: an inseparable triad? J Vasc Bras. 2015; 14(4):319–327. 10.1590/1677-5449.04315 [DOI] [Google Scholar]
  • 31.Muennig P, Jia H, Lee R, Lubetkin E. I Think Therefore I Am: Perceived Ideal Weight as a Determinant of Health. Am J Public Health 2008; 98(3): 501–506. 10.2105/AJPH.2007.114769 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Castelo-Branco C. Clinical aspects and relationships between weight gain, obesity and menopause. Maturitas. 2009; 63 (Suppl 1): S19 10.1016/S0378-5122(09)70075-1 [DOI] [Google Scholar]
  • 33.Gershuni V, Li YR, Williams AD, So A, Steel L, Carrigan E, et al. Breast cancer subtype distribution is different in normal weight, overweight, and obese women. Breast Cancer Res Treat. 2017;163(2):375–381. 10.1007/s10549-017-4192-x [DOI] [PubMed] [Google Scholar]
  • 34.Blümel JE, Chedraui P, Aedo S, Fica J, Mezones-Holguín E, Barón G, et al. Obesity and its relation to depressive symptoms and sedentary lifestyle in middle-aged women. Maturitas. 2015; 80(1):100–5. 10.1016/j.maturitas.2014.10.007 [DOI] [PubMed] [Google Scholar]
  • 35.Sorpreso ICE, Soares Júnior JM, Fonseca AM, Baracat EC. Female aging. Rev Assoc Med Bras 2015; 61(6):553–556. 10.1590/1806-9282.61.06.553 [DOI] [PubMed] [Google Scholar]
  • 36.Skrypnik D, Bogdański P, Zawiejska A, Wender-Ożegowska E. Role of gestational weight gain, gestational diabetes, breastfeeding, and hypertension in mother-to-child obesity transmission. Pol Arch Intern Med. 2019; 129: 267–275. 10.20452/pamw.4426 [DOI] [PubMed] [Google Scholar]
  • 37.Rosaneli CF, Auler F, Manfrinato CB, Rosaneli CF, Sganzerla C, Bonatto MG et al. Evaluation of the prevalence and nutritional and social determinants of overweight in a population of schoolchildren: a cross-sectional analysis of 5,037 children. Rev. Assoc. Med. Bras. 2012;58 (4): 472–476. 10.1590/S0104-42302012000400019 [DOI] [PubMed] [Google Scholar]
  • 38.Simmonds M, Burch J, Llewellyn A, Griffiths C, Yang H, Owen C. The use of measures of obesity in childhood for predicting obesity and the development of obesity-related diseases in adulthood: a systematic review and meta-analysis. Health Technol Assess. 2015. June;19(43):1–336. 10.3310/hta19430 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Alves RFS, Faerstein E. Educational inequality in the occurrence of abdominal obesity: Pró-Saúde Study. Rev Saude Publica. 2015;49: 65 10.1590/S0034-8910.2015049005786 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Lins APM, Sichieri R, Coutinho WF, Ramos EG, Peixoto MVM, Fonseca VM. Healthy eating, schooling and being overweight among low-income women. Ciência & Saúde Coletiva. 2013;18(2):357–66. 10.1590/S1413-81232013000200007 [DOI] [PubMed] [Google Scholar]
  • 41.Freire RS, Lélis FLO, Fonseca Filho JA, Nepomuceno MO, Silveira MF. Regular physical activity: a population-based study in North Minas Gerais, Brazil. Rev Bras Med Esporte. 2014; 20(5):345–349. 10.1590/1517-86922014200502062 [DOI] [Google Scholar]
  • 42.Skrypnik D, Bogdański P, Skrypnik K, Mądry E, Karolkiewicz J, Szulińska M, Suliburska J, Walkowiak J. Influence of endurance and endurance-strength training on mineral status in women with abdominal obesity: a randomized trial. Medicine (Baltimore). 2019;98(12):e14909 10.1097/MD.0000000000014909 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Skrypnik K, Bogdariski P, Sobieska M, Suliburska J. The effect of multistrain probiotic supplementation in two doses on iron metabolism in obese postmenopausal women: a randomized trial. Food & Function. 2019; 10:5228–5238. 10.1039/C9FO01006H [DOI] [PubMed] [Google Scholar]
  • 44.Kac G, Velásquez-Meléndez G, Valente JG. Menarche, early pregnancy, and obesity in selected Brazilian women from a health care center in Belo Horizonte, Minas Gerais, Brazil. Cad Saúde Pública. 2003; 19(Suppl. 1):111–8. 10.1590/S0102-311X2003000700012 [DOI] [PubMed] [Google Scholar]
  • 45.Bobrow KL, Quigley MA, Green J, Reeves GK, Beral V; Million Women Study Collaborators. Persistent effects of women's parity and breastfeeding patterns on their body mass index: results from the Million Women Study. Int J Obes (Lond). 2013; 37(5):712–7. 10.1038/ijo.2012.76 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Sim JH, Chung D, Lim JS, Lee MY, Chung CH, Shin JY, et al. Maternal Age at First Delivery Is Associated with the Risk of Metabolic Syndrome in Postmenopausal Women: From 2008–2010 Korean National Health and Nutrition Examination Survey. PLoS ONE. 2015; 10(5): e0127860 10.1371/journal.pone.0127860 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.We JS, Han K, Kwon HS, Kil K. Effect of Maternal Age at Childbirth on Obesity in Postmenopausal Women: A Nationwide Population-Based Study in Korea. Medicine (Baltimore). 2016; 95(19):e3584 10.1097/MD.0000000000003584 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Vladutiu CJ, Siega-Riz AM, Sotres-Alvarez D, Stuebe AM, Ni A, Tabb KM, et al. Parity and Components of the Metabolic Syndrome Among US Hispanic/Latina Women: Results From the Hispanic Community Health Study/Study of Latinos. Circ Cardiovasc Qual Outcomes. 2016; 9 (2 Suppl 1): S62–9. 10.1161/CIRCOUTCOMES.115.002464 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Kim JH, Lee SJ. Parity and increased risk of insulin resistance in postmenopausal women: the 2010 Korean National Health and Nutrition Examination Survey. Menopause. 2017;13 10.1097/GME.0000000000000846 [DOI] [PubMed] [Google Scholar]
  • 50.Jung JH, Song GG, Ji JD, Lee YH, Kim JH, Seo YH, et al. Metabolic syndrome: prevalence and risk factors in Korean gout patients. Korean J Intern Med. 2018. 10.3904/kjim.2016.062 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Lopes HF, Corrêa-Giannella ML, Consolim-Colombo FM, Egan BM. Visceral adiposity syndrome. Diabetol Metab Syndr. 2016; 8:40 10.1186/s13098-016-0156-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Zhang JW, He LJ, Cao SJ, Yang Q, Yang SW, Zhou YJ. Association of serum uric acid and coronary artery disease in premenopausal women. PLoS One. 2014; 9(9):e106130 10.1371/journal.pone.0106130 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Zhang L, Spencer KL, Voruganti VS, Jorgensen NW, Fornage M, Best LG et al. Association of functional polymorphism rs2231142 (Q141K) in the ABCG2 gene with serum uric acid and gout in 4 US populations: the PAGE Study. Am J Epidemiol. 2013; 177(9):923–32. 10.1093/aje/kws330 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Sesso RC, Lopes AA, Thomé FS, Lugon JR, Martins CT. Brazilian Chronic Dialysis Census 2014. J Bras Nefrol. 2016; 38(1): 54–61. 10.5935/0101-2800.20160009 [DOI] [PubMed] [Google Scholar]
  • 55.Stefanska A, Bergmann K, Sypniewska G. Metabolic Syndrome and Menopause: Pathophysiology, Clinical and Diagnostic Significance. Adv Clin Chem. 2015;72:1–75. 10.1016/bs.acc.2015.07.001 [DOI] [PubMed] [Google Scholar]
  • 56.Garofalo C, Borrelli S, Minutolo R, Chiodini P, De Nicola L, Conte G. A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population. Kidney Int. 2017; 91(5):1224–1235. 10.1016/j.kint.2016.12.013 [DOI] [PubMed] [Google Scholar]
  • 57.Sharma S, Aggarwal N, Joshi B. Suri V, Badada S. Prevalence of metabolic syndrome in pre- and post-menopausal women: A prospective study from apex institute of North India. J Midlife Health. 2016. Oct-Dec; 7(4): 169–174. 10.4103/0976-7800.195695 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Meirelles RMR. Menopause and metabolic syndrome. Arq Bras Endocrinol Metab. 2014;58(2):91–6. 10.1590/0004-2730000002909 [DOI] [PubMed] [Google Scholar]
  • 59.Figueiredo Neto JA, Figuerêdo ED, Barbosa JB, Barbosa FF, Costa GRCC, Nina VJS et al. Metabolic Syndrome and Menopause: Cross-Sectional Study in Gynecology Clinic. Arq Bras Cardiol 2010; 95(3): 339–45. 10.1590/s0066-782x2010005000094 [DOI] [PubMed] [Google Scholar]
  • 60.Agência Nacional de Saúde Suplementar (Brasil). Diretoria de Normas e Habilitação dos Produtos. Gerência-Geral de Regulação Assistencial. Gerência de Monitoramento Assistencial. Coordenadoria de Informações Assistenciais. Manual de diretrizes para o enfretamento da obesidade na saúde suplementar brasileira [recurso eletrônico]/Agência Nacional de Saúde Suplementar. Diretoria de Normas e Habilitação dos Produtos. Gerência-Geral de Regulação Assistencial. Gerência de Monitoramento Assistencial. Coordenadoria de Informações Assistenciais.–Rio de Janeiro: ANS, 2017. 6.5 MB; ePUB. ISBN 978-85-63059-36-9. Available at: http://www.ans.gov.br/images/Manual_de_Diretrizes_para_o_Enfrentamento_da_Obesidade_na_Sa%C3%BAde_Suplementar_Brasileira.pdf
  • 61.Silver HJ, Kang H, Keil CD, Muldowney JA, Kocalis H, Fazio S, et al. Consuming a balanced high fat diet for 16 weeks improves body composition, inflammation and vascular function parameters in obese premenopausal women. Metabolic. 2014; 63(4):562–73. 10.1016/j.metabol.2014.01.004 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Nayanatara Arun Kumar

7 Aug 2019

PONE-D-19-15143

HEALTH CONDITIONS ASSOCIATED WITH OVERWEIGHT IN CLIMACTERIC WOMEN

PLOS ONE

Dear  Authors

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. 

Please incorporate the reviewers comments step by step of both the reviewers 

We would appreciate receiving your revised manuscript by Sep 21 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Nayanatara Arun Kumar

Academic Editor

PLOS ONE

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service.  

Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (http://learn.aje.com/plos/) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (www.editage.com) and enter referral code PLOSEDIT for a 15% discount off Editage services.  If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free.

Upon resubmission, please provide the following:

  • The name of the colleague or the details of the professional service that edited your manuscript

  • A copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a *supporting information* file)

  • A clean copy of the edited manuscript (uploaded as the new *manuscript* file)

3. Please provide the full name of the ethics committee which approved this study in the ethics statement in your manuscript and the online submission form.

4.  Please cite and discuss the following related work:  

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0211617

Please cite and incorporate your response related to this related paper to the body of the manuscript (introduction and discussion). Please bear in mind that our publication criteria state " If a submitted study replicates or is very similar to previous work, authors must provide a sound scientific rationale for the submitted work and clearly reference and discuss the existing literature. Submissions that replicate or are derivative of existing work will likely be rejected if authors do not provide adequate justification.

5. Please remove your figures from within your manuscript file, leaving only the individual TIFF/EPS image files, uploaded separately.  These will be automatically included in the reviewers’ PDF.

6. ** Please include your tables as part of your main manuscript and remove the individual files **. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thanks for your invitation. I reviewed the manuscript “PONE-D-19-15143 “(HEALTH CONDITIONS ASSOCIATED WITH OVERWEIGHT IN CLIMACTERIC WOMEN), the following is my comments:

1. It is necessary that for authors to find someone who is familiar with English to revise this paper.

2. The authors seemed to be unclear about the independent variables and outcome variables; we can find this confused expression in both of abstracts and the main paper.

3. Regression models are common used in study these years, authors do need to explain their analysis step by step, and the tables are substandard.

4. Some part of discussion is irrelevant with the results.

In view of the above reasons, I cannot give my specific suggestion about this paper.

Reviewer #2: I was honored to review the manuscript entitled “Health conditions associated with overweight in climacteric women” submitted to Plos One.

The paper presents interesting and good quality study; the aim of this study was to investigate the association between health conditions and overweight in climacteric women assisted by primary care professionals..

I recommend to accept the manuscript after minor revision.

There are also some other points to correct:

- please provide the list of abbreviations.

- did you perform body composition analisis?

- Introduction and Discussion section needs improvement- please cite: doi:

10.1039/C9FO01006H ; 10.20452/pamw.4426. ; 10.1097/MD.0000000000014909.

- In discussion please provide “study strong points” and “study limitation” section.

I recommend to accept the manuscript after minor revision.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2019 Dec 12;14(12):e0218497. doi: 10.1371/journal.pone.0218497.r002

Author response to Decision Letter 0

20 Oct 2019

REBUTTAL LETTER

Journal Requirements

1. When submitting your revision, we need you to address these additional requirements.

RESPONSE: Thank you for your observation. We have reviewed and sought to meet PLOS ONE's style requirements.

2. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service.

RESPONSE: We apologize for the English language errors. This issue has been solved since all the text was submitted for editing by the AJE team.

3. Please provide the full name of the ethics committee which approved this study in the ethics statement in your manuscript and the online submission form.

RESPONSE: Thank you for your observation. The full name of the ethics committee that approved this study has been provided in the ethics statement in our manuscript (Line 181-182).

4. Please cite and discuss the following related work: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0211617

RESPONSE: Thank you for your observation. The work was cited (Line 58).

The present work is not a replication of prior research but research that is part of a project called “Health problems of climacteric women: an epidemiological study”, which was developed by a research group linked to a postgraduate programme. Strictly speaking, the central theme is the health of climacteric women. This group consists of several researchers who each dealing with one of the following lines of research: metabolic syndrome, mental health, obesity, quality of life, sleep disorders, health perception, urinary incontinence, climacteric symptoms, and levels of physical activity. Thus, the work now presented is a product of the obesity in climacteric women line of research (Line 75-82).

5. Please remove your figures from within your manuscript file, leaving only the individual TIFF/EPS image files, uploaded separately. These will be automatically included in the reviewers’ PDF.

RESPONSE: Thank you for your observation. The figure have been removed from the manuscript file.

6. ** Please include your tables as part of your main manuscript and remove the individual files **. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files

RESPONSE: Thank you for your observation. The tables have been included as part of the main manuscript and removed from their individual files.

Reviewer #1

Comment 1

“It is necessary that for authors to find someone who is familiar with English to revise this paper”.

RESPONSE: We apologize for the English language errors. This issue has been solved since all the text was submitted for editing by the AJE team.

Comment 2

“The authors seemed to be unclear about the independent variables and outcome variables; we can find this confused expression in both of abstracts and the main paper.

RESPONSE: The suggestion was followed, and the text was changed. The outcome variable is overweight/obesity (Line 35/110-111). Thank you for the suggestion.

Comment 3

“Regression models are common used in study these years, authors do need to explain their analysis step by step, and the tables are substandard.”

RESPONSE: The work was performed following the methodological rigor for random sampling, and a considerable number of participants were included. The data collectors were calibrated, and prior to collection, a pilot study was performed. The statistical analysis was conducted appropriately, and the tables were checked by the authors. Thank you for the suggestion (Line 94-97/102-107/ 311-313).

Comment 4

“Some part of discussion is irrelevant with the results”:

RESPONSE: The discussion was reviewed by the authors, including suggestions made by the reviewers. Thank you for the suggestion (Line 249-250/252-254/261-265).

Reviewer #2

Comment 1

“please provide the list of abbreviations.

RESPONSE: The suggestion was followed, and the text was changed. All the meanings of the acronyms have been contemplated in the text. Thank you for the suggestion.

AMI acute myocardial infarction

BDI Beck Depression Inventory

BMI body mass index

CAD coronary artery disease

CI confidence interval

CKD chronic renal disease

DEXA dual X-ray absorptiometry

FHS Family Health Strategy

FSH follicle stimulating hormone

HDL high-density lipoprotein

ICIQ-SF™ International Consultation on Incontinence Questionnaire - Short Form

IPAQ International Physical Activity Questionnaire

LDL low-density lipoprotein

MG Minas Gerais

MS metabolic syndrome

NCEP/ATP-III Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults

NHA National Health Agency

NHC National Health Council

PHC Primary Health Care

PR prevalence ratios

S stature

SAH systemic arterial hypertension

SOBRAC Brazilian Climacteric Society

SPSS Statistical Package for the Social Sciences

VLDL very low-density lipoprotein

W weight

Comment 2

“did you perform body composition analisis?”

RESPONSE: The study used BMI as a diagnostic criterion of overweight/obesity as opposed to using other gold standard techniques, such as X-ray double emission densitometry (DEXA), which allows the analysis of body composition. However, it should be noted that although the use of BMI is a limiting factor, its use is supported by the acceptance of BMI as a diagnostic criterion for obesity by the World Health Organization (Line 311-323).

Comment 3

“Introduction and Discussion section needs improvement- please cite: doi: 10.1039/C9FO01006H; 10.20452/pamw.4426.; 10.1097/MD.0000000000014909.”

RESPONSE: These have been cited. Thank you for the suggestion (Line 249-250/252-254/ 261-265).

Comment 4

“In discussion please provide “study strong points” and “study limitation” section.

RESPONSE: This was a randomized, probabilistic sample of a representative size, with methodological rigor, data collector training and a pilot study. All of the study procedures were conducted according to current legislation in relation to research ethics. Study limitation: This was a prevalence study that does not allow the establishment of cause-effect conclusions, and there was no use of DEXA for body analysis (Line 311-323/ 330-332).

Attachment

Submitted filename: Response to Reviewers.docx

Click here for additional data file. (24.1KB, docx)

Decision Letter 1

Nayanatara Arun Kumar

20 Nov 2019

HEALTH CONDITIONS ASSOCIATED WITH OVERWEIGHT IN CLIMACTERIC WOMEN

PONE-D-19-15143R1

Dear Dr Fernanda Piana Santos Lima de Oliveira

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

With kind regards,

Nayanatara Arun Kumar

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Dear authors

I appreciate the efforts and the corrections done by as per the guidance of all the respectable reviewers

Reviewers' comments:

Acceptance letter

Nayanatara Arun Kumar

5 Dec 2019

PONE-D-19-15143R1

Health conditions associated with overweight in climacteric women

Dear Dr. Piana Santos Lima de Oliveira:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

For any other questions or concerns, please email plosone@plos.org.

Thank you for submitting your work to PLOS ONE.

With kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Nayanatara Arun Kumar

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. DATABASE.

    (SAV)

    Click here for additional data file. (454.4KB, sav)
    Attachment

    Submitted filename: Response to Reviewers.docx

    Click here for additional data file. (24.1KB, docx)

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.

    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES